Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Torbenson

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Hepatology (Baltimore, Md.)|March 20, 2009
MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3Florin M Selaru, Alexandru V Olaru, Takatsugu Kan, et al.
Histopathology|May 22, 2024
Severe acute liver disease in adults: Contemporary role of histopathologyAndrew D Clouston, Annette S H Gouw, Dina Tiniakos, et al.
Human Pathology|October 24, 2025
Porto-sinusoidal vascular disorder (PSVD): Survey-based analysis of the usage and drawbacks of this newly proposed terminologyNazire E Albayrak, Dhanpat Jain, Michael Torbenson, et al.
The American Journal of Pathology|September 6, 2011
Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypesChristopher M Heaphy, Andrea P Subhawong, Seung-Mo Hong, et al.
The Oncologist|September 19, 2025
First-line atezolizumab/bevacizumab or durvalumab/tremelimumab in advanced hepatocellular carcinoma: a real world, multicenter retrospective studyIoannis Kournoutas, Paulina Marell, Jennifer Gile, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Hepatology (Baltimore, Md.)|March 20, 2009
MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3Florin M Selaru, Alexandru V Olaru, Takatsugu Kan, et al.
Histopathology|May 22, 2024
Severe acute liver disease in adults: Contemporary role of histopathologyAndrew D Clouston, Annette S H Gouw, Dina Tiniakos, et al.
Human Pathology|October 24, 2025
Porto-sinusoidal vascular disorder (PSVD): Survey-based analysis of the usage and drawbacks of this newly proposed terminologyNazire E Albayrak, Dhanpat Jain, Michael Torbenson, et al.
The American Journal of Pathology|September 6, 2011
Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypesChristopher M Heaphy, Andrea P Subhawong, Seung-Mo Hong, et al.
The Oncologist|September 19, 2025
First-line atezolizumab/bevacizumab or durvalumab/tremelimumab in advanced hepatocellular carcinoma: a real world, multicenter retrospective studyIoannis Kournoutas, Paulina Marell, Jennifer Gile, et al.
Pageof 14